SG Americas Securities, LLC
Broker-DealerPosition in NBIX — Neurocrine Biosciences Inc
CIK 1313360
NEW YORK, NY
Position in NBIX
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$7,807,834
-$11,272,555 QoQ
Shares Held
59,267
-55.9% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SG Americas Securities, LLC holds $233,543,492 across 35 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
4,812,814 | $65,021,117 | |
| 2 | ZTS |
Zoetis Inc.
|
290,332 | $34,320,145 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
640,179 | $30,824,618 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
780,518 | $23,509,202 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
377,213 | $19,498,139 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
23,113 | $13,705,546 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
710,876 | $8,836,188 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
59,267 | $7,807,834 |
All Filings in NBIX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,807,834 | 59,267 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $19,080,389 | 134,530 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $2,132,512 | 15,191 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $607,585 | 4,834 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $19,422,797 | 175,613 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $144,963 | 1,062 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $931,438 | 8,084 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $5,847,946 | 42,478 | Shares | Sole | 2024-07-12 | |
| 2023-12-31 | $946,036 | 7,180 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $2,750,962 | 24,453 | Shares | Sole | 2023-10-13 | |
| 2023-03-31 | $3,039,636 | 30,030 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $878,361 | 7,354 | Shares | Sole | 2023-02-02 | |
| 2022-06-30 | $2,017,836 | 20,700 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $4,054,968 | 43,253 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $3,690,330 | 43,329 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $3,663,570 | 38,198 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $3,403,767 | 34,975 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,310,919 | 54,611 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $629,926 | 6,572 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,531,636 | 15,928 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,384,944 | 11,352 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,572,267 | 18,166 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||